Whitefield

Quick links to important sections

Whitefield

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Whitefield

Quick Facts

Property Description
Active Ingredients Benzoic Acid [INN] and Salicylic Acid [INN]
Form Ointment (Semi-solid)
Pharmacological Class Topical Antifungal and Keratolytic Agent
Common Use Management of fungal-related scaling skin conditions
Origin Synthetic combination

What Type of Medicine is Compound Benzoic Acid Ointment?

Compound Benzoic Acid Ointment (historically known as Whitfield's Ointment) is a classic, externally applied combination medicine classified as both a Topical Antifungal and a Keratolytic Agent. This unique, dual-action approach reflects the product's design to manage skin conditions characterized by both microbial activity and excessive scaling of the skin surface. Its status as an established therapeutic option is recognized globally, with its inclusion on essential medicines lists demonstrating its historical role in managing topical fungal therapy. The formulation is generally considered a synthetic combination and is often available for use by adult and adolescent patient groups.

Composition and General Purpose

The efficacy of the ointment is derived from its two active ingredients [INN]: Benzoic Acid and Salicylic Acid, which are dispersed within a semi-solid ointment base, typically a form of Petrolatum. This specific presentation is intended solely for topical application. The Benzoic Acid component provides the essential antifungal and antiseptic activity, hindering fungal growth. Conversely, Salicylic Acid acts as a keratolytic agent, supporting the shedding and removal of thickened, rigid outer skin layers. Pharmacological recognition confirms that the keratolytic action aids the antifungal component in achieving optimal access and therapeutic effect. Therefore, the general purpose is to promote skin recovery by combining microbial control with physical exfoliation of the affected epidermis.

What side effects are possible with Whitefield?

Possible Side Effects and Safety Information

The official safety profile for Compound Benzoic Acid Ointment (Whitefield's Ointment) is defined by its topical application and the known properties of its active ingredients, Salicylic Acid and Benzoic Acid. Adverse reactions are grouped by frequency and the organ system affected, according to regulatory standards.

Adverse Reaction Scope

Category Regulatory Description
Common Reactions Local application site effects, including a warmth, stinging, or burning sensation that may be transient and occur immediately after use. Skin irritation, redness (erythema), and peeling (exfoliation) are also documented as common.
System-Organ Classes Primarily Skin and Subcutaneous Tissue Disorders. Immune System Disorders are also documented due to the potential for allergic reactions.
Serious Adverse Reaction Potential for severe hypersensitivity reactions, including generalized allergic contact dermatitis, which is documented but considered rare or very rare in some regulatory texts.

Regulatory Safety Constraints

The regulatory documentation provides specific limitations to mitigate the risk of systemic exposure:

  • Hypersensitivity: The ointment is contraindicated in individuals with a known allergy to Benzoic Acid or Salicylic Acid.
  • Pediatric Use: Use is generally restricted or not recommended in young children (under 2 years of age) due to the higher risk of systemic absorption of salicylates and potential for toxicity.
  • Application Boundary: The preparation must not be applied to the eyes, mucous membranes, or open wounds/denuded skin areas, as this significantly increases the risk of absorption.
  • Exposure Pattern: Caution is advised regarding prolonged use or application over large areas of the body, as this may increase the potential for systemic exposure and related adverse effects.

Connection to the Overall Safety Profile

The official safety information establishes that the primary risk associated with Whitefield is the localized irritation at the application site, which is common and expected. The most critical safety constraint is the need to strictly limit use in high-risk scenarios and populations, such as young children or when the skin barrier is broken, to prevent the officially documented risk of systemic salicylate exposure.

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose profile for this product is structured around the risk of systemic toxicity, classified as salicylism, arising primarily from the absorption of the Salicylic Acid component. This event is documented to follow accidental ingestion or prolonged application over large areas of the skin.

Regulator-documented signs of salicylism include common manifestations such as tinnitus, vomiting, dizziness, dehydration, and hyperventilation. Severe poisoning is officially documented to escalate to serious outcomes, including convulsions, coma, renal failure, and pronounced metabolic acidosis.

Urgent action is required: regulatory guidance mandates that patients seek immediate medical attention or contact emergency services immediately upon any suspicion of overdose. The management principle is officially defined as symptomatic and supportive, and no specific antidote is known. Procedural steps for severe intoxication may include haemodialysis and urinary alkalinisation. Furthermore, regulatory documents note that patients under ten years and over 70 are documented to be at an increased risk of toxicity and may require special monitoring.

Therapeutic Uses of Whitefield

Quick Facts

  • Therapeutic Domain: Addresses select localized fungal infections of the skin.
  • Associated Conditions: Supports management of athlete’s foot and ringworm.

Whitefield is a topical preparation indicated for the management of certain superficial fungal infections that affect the skin. Its therapeutic use focuses on conditions such as tinea pedis (athlete's foot) and tinea corporis (ringworm), where it may contribute to the resolution of symptoms. The application is intended to manage the discomfort, itching, and irritation associated with these localized infections.

In addition to its primary use in dermatophyte infections, Whitefield may be considered as a supportive measure in other hyperkeratotic and scaling skin conditions, including specific presentations of eczema and psoriasis. The preparation is part of a therapeutic regimen to encourage the shedding of rough, dead skin cells and promote the temporary relief of associated symptoms.

Regulatory References

  1. NIH MedlinePlus guidance on product use

Eligibility and Restrictions for Use

Whitefield (a combination of benzoic acid and salicylic acid) is an antifungal and keratolytic medication used for the topical treatment of fungal skin infections, such as ringworm, in adults and children.

Who Can Use Whitefield?

  • Adults and Children: The ointment is generally considered suitable for topical use in adults and children, though the dosage for children may need adjustment by a healthcare provider, and it is generally not recommended for neonates.
  • Targeted Condition: Individuals diagnosed with superficial fungal skin infections (dermatophytosis) like tinea pedis (athlete's foot) or tinea corporis (ringworm).

Who Cannot Use Whitefield?

  • Hypersensitivity: Patients who have a known allergy or sensitivity to salicylate (including aspirin), benzoic acid, or any other ingredient in the formulation should not use this product.
  • Specific Skin Conditions: It should not be applied to skin that is broken, inflamed, weeping, sunburned, or irritated, nor on skin affected by psoriasis or eczema.
  • Pregnancy and Lactation: Use during pregnancy or breast-feeding is typically advised only with a healthcare professional's guidance, as the ingredients may be absorbed systemically.
  • Special Considerations: Due to the risk of systemic absorption and potential toxicity, the ointment should not be used for prolonged periods or over very large areas of the body without medical supervision. Patients with impaired peripheral circulation or diabetes should use the product with caution on extremities.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Compound Benzoic Acid Ointment (Whitefield's Ointment) documents a limited interaction scope, primarily concerning its application site and low systemic exposure.

No Systemic Drug Interactions Known

Official regulatory documents confirm that there are no known interactions with Whitefield's Ointment regarding systemic drug combinations. This is consistent with its intended topical route of administration and minimal systemic absorption when used as directed.

Interaction Classification Description (from Regulatory Labeling)
Systemic PK Interactions None documented for oral or non-topical medicines
Pharmacodynamic Effect Increased absorption of other topically applied medicines

Interaction-Related Restrictions

The most significant documented interaction is a local pharmacodynamic effect resulting from the keratolytic action of the Salicylic Acid component. This action may increase the skin's permeability, potentially increasing the exposure of other medicinal products applied to the same skin area.

This leads to an official restriction: Concomitant use of Whitefield’s Ointment and other topical medicines on the same area of skin should therefore be avoided. This constraint is in place to manage the risk of altered topical drug exposure and enhanced effects of the co-administered products.

Additionally, systemic toxicity is cautioned under conditions of misuse. The label notes that symptoms of acute salicylate poisoning have been reported following prolonged application to large areas of the body or broken skin, linking high absorption to a systemic risk.

Mechanism of Action

How Whitefield Works: Mechanism of Action

The mechanism of Compound Benzoic Acid Ointment is defined by a synergistic two-component approach that simultaneously targets microbial energy pathways and structurally modulates the skin barrier where the organisms reside.

Dual-Action Pathway Interference: Antifungal Component

Benzoic Acid affects fungal biology by acting on its metabolic processes. The ingredient is absorbed by the fungal cell in its undissociated form, leading to a critical drop in intracellular pH. This shift acts as an inhibitor of key glycolytic enzymes, such as phosphofructokinase, thereby restricting the fungus's energy production. The resulting physiological effect is fungistasis—a localized cessation of organism growth and proliferation.

Epidermal Barrier Modulation and Desmolytic Action

Salicylic Acid explains the structural mechanism by functioning as a desmolytic agent. It reduces the adhesive strength between corneocytes in the stratum corneum by disrupting the intercellular cement and desmosomal attachments. The resulting physiological effect is the accelerated desquamation (shedding) of the thickened outer skin layers, leading to the physical removal of the outer, affected skin layers.

Mechanistic Synergy: Enhanced Penetration

This domain addresses how the mechanisms of the two acids complement one another to enhance the mechanism's overall output. The desmolytic action thins the epidermal barrier and removes the hyperkeratotic layers. This structural modulation enhances the local tissue permeability, providing the Benzoic Acid with enhanced local access to its fungal targets. This synergy reinforces the metabolic inhibition and is a key factor in shaping the drug's pharmacodynamic characteristics.

Dosage and Administration Information

The Compound Benzoic Acid Ointment, historically known as Whitefield's Ointment, is administered exclusively via the topical route for external application to the skin. The strength is formalized as an ointment containing 6% w/w Benzoic Acid and 3% w/w Salicylic Acid.


Administration Schedule and Dosing

The medicine is applied on a fixed twice-daily schedule, with applications typically occurring in the morning and evening. Standard instructions specify applying only a thin layer of the ointment directly onto the affected area of the skin. For adults, dosing guidance may restrict the quantity to no more than three fingertip units (FTU) at any single time. The overall course duration typically requires continuous application for several weeks to allow for the complete shedding of the affected layers of skin.


Procedural Contexts

Established conditions define the parameters for proper use. Prior to application, the affected skin area should be cleaned and dried. A primary procedural restriction is the avoidance of occlusion; the treated area must not be covered with bandages or dressings unless a healthcare professional specifically directs it. The standard twice-daily regimen applies broadly to adults, adolescents, and the elderly; however, use in children under the age of 16 requires explicit medical direction.

Recent Clinical Evidence

Research evidence / Overview of studies

Overview of Clinical Trial Findings

Whitefield's Ointment, historically used for superficial fungal infections, combines salicylic acid (a keratolytic agent) and benzoic acid (which has antifungal properties). Research examined the drug to study potential differences in patient-reported data in clinical trials.

Studies focused on comparing the traditional formulation (or solution derived from it) with newer topical antifungal agents, often in combination with oral medications, for fungal foot infections (tinea pedis) and other dermatophytosis.

Key endpoints studied include:

  • Mycological Cure Rate: Comparing the proportion of patients achieving a negative result on fungal tests (e.g., KOH test) at defined intervals (e.g., 4 and 8 weeks).
  • Clinical Efficacy: Assessing the reduction in mean signs and symptoms scores.

Studies documented observations regarding differences in reported symptoms and quality of life compared to placebo and were generally found to be similarly efficacious to certain newer topical antifungals in some tinea infections.


Dosage and Safety Profile

Studies utilizing the components of the drug have examined its use over extended periods, and findings suggest that the incidence of adverse events is low.

  • Side Effect Frequency: Clinical trials documented the incidence of common and serious adverse events. Adverse events were frequently documented as mild-to-moderate in severity. These commonly include localized skin irritation, such as a burning sensation, which is typically mild and may occur during application.
  • Drug Interactions: No known major interactions have been widely reported in clinical reviews.
  • Use in Specific Populations: Studies do not provide clear evidence regarding the evaluation of this medication for individuals with severe hepatic (liver) impairment. Evidence also remains limited concerning its use during pregnancy or breastfeeding, and it is not yet clear whether the drug is associated with any effects in these populations.

Key Studies & References

  1. Effectiveness of modified Whitfield's ointment with oral griseofulvin in the treatment of dermatophytosis poorly responsive to standard antifungal therapy: a randomized, double blind, within patient placebo control
  2. Treatment of difficult-to-treat-dermatophytosis: results of a randomized, double-blind, placebo-controlled study
  3. Summary of Product Characteristics (SmPC) / Patient Information Leaflet (PIL) for Whitfield's Ointment (Benzoic Acid/Salicylic Acid)

Frequently Asked Questions (FAQ)

Common questions about Whitefield (FAQ)


Q: Is Whitefield ointment the same as the generic combination of Salicylic Acid and Benzoic Acid?

A: Yes, Whitefield’s Ointment is the historical name for the medicine officially designated as Compound Benzoic Acid Ointment. This formulation consistently contains the active ingredients Benzoic Acid and Salicylic Acid in an ointment base, typically at concentrations of 6% w/w and 3% w/w, respectively.


Q: What specific types of fungal infections can Whitefield be used to treat?

A: According to official product information, Whitefield’s Ointment is indicated for the external treatment of dermatophytosis, which is the class of superficial fungal skin infections. This indication covers common conditions such as athlete's foot (tinea pedis) and ringworm (tinea corporis).


Q: How quickly does Whitefield ointment usually start working for athlete's foot?

A: Clinical cure usually requires a course of several weeks of continuous application, as the product works by helping the affected skin layers shed. Regulatory warnings advise that if symptoms worsen or do not show improvement after a certain period (e.g., 7 days), consulting a healthcare professional is appropriate.


Q: How long should the burning or warm sensation last after application?

A: Official safety information notes that initial reactions like a warm or burning sensation at the application site are common and typically transient (temporary). In cases of severe burning or if the sensation persists beyond the expected transient period (e.g., more than 10 days), official safety information suggests seeking advice from a healthcare professional.


Q: Can Whitefield ointment cause drying or peeling of the skin?

A: Yes, common side effects documented in the official safety profile include skin irritation and peeling, or exfoliation. This is due to the keratolytic (skin-shedding) action of the Salicylic Acid component. If drying or irritation becomes excessive, it is advised to seek guidance from a healthcare professional regarding continued use.


Q: Is there an interaction between Whitefield and common products like soap or alcohol-based sanitizers?

A: Regulatory documents do not specifically list interactions with common soaps or sanitizers. However, application guidelines stress that the affected area must be cleaned and dried before use. Furthermore, the ointment is restricted from use on skin that is already irritated, broken, or sunburned.


Q: What happens if I stop using Whitefield as soon as the symptoms clear up?

A: Official administration guidance advises using the product for the full duration recommended by a healthcare provider, even if symptoms appear to clear up earlier. Since the treatment course may take several weeks, discontinuing treatment early may be associated with a risk of recurrence of the fungal infection.


Q: Does Whitefield ointment have an expiry date, and how should it be stored?

A: Yes, like all medicines, Whitefield's Ointment has an expiry date. Official storage instructions typically require the product to be kept in a tightly closed container, protected from light and moisture, at a temperature generally not exceeding 25 C or 30 C. It is prohibited from being frozen.


Q: Why is Whitefield sometimes advised to be diluted for use on thinner skin areas?

A: The full-strength ointment can be irritating, especially on sensitive areas. Due to the risk of irritation, regulatory cautions generally advise avoiding use in sensitive or highly-irritated areas. While some historical use notes mention dilution, current labeling typically advises against use in these delicate areas altogether.


Q: Can Whitefield be used for jock itch (tinea cruris)?

A: The product is indicated for the general class of fungal skin infections known as dermatophytosis, of which jock itch (tinea cruris) is a common type. However, official cautions recommend avoiding use on highly sensitive or thinner skin areas, such as the groin, where irritation or absorption is more likely.


Q: Does applying a thicker layer of Whitefield make it work better or just increase side effects?

A: Official instructions specify applying only a thin layer of the ointment twice daily. Applying more than the recommended amount does not guarantee better results and may instead increase the risk of localized skin irritation or lead to enhanced systemic absorption of the ingredients.


Q: Does Whitefield ointment lose its effectiveness if it gets too warm?

A: Yes. The product is required to be stored within a specific temperature range, typically not exceeding 25 C to 30 C. Official storage requirements must be followed, as storing the ointment outside of the recommended temperature range may compromise its stability, potentially impacting its effectiveness.


Q: Why is it important to wash hands before and after applying Whitefield?

A: The application process requires cleaning and drying the affected area first. Furthermore, regulatory guidance advises washing your hands thoroughly after applying the ointment. This procedure helps prevent the accidental transfer of the medicine to sensitive areas like the eyes or mucous membranes.


Q: Is it normal for the affected skin to look whiter or shed after using Whitefield?

A: Yes. Peeling or exfoliation is a commonly reported side effect, and the desmolytic mechanism is designed to cause the shedding of the affected outer skin layers. This shedding may be accompanied by a change in the skin’s appearance in the treated area.


Q: Why is the full scientific name Benzoic Acid and Salicylic Acid Topical?

A: The full scientific designation, Benzoic Acid and Salicylic Acid Topical, is used because it precisely identifies the two active ingredients in the product. The term 'Topical' indicates the designated route of administration, meaning the product is intended only for application to the surface of the skin.


Q: Does the inclusion of the ointment base (like petrolatum) affect how well Whitefield works?

A: The semi-solid ointment base, often petrolatum, is the required vehicle for the active ingredients. This formulation is designed to ensure the product stays on the skin's surface and helps the ingredients achieve local access to their fungal targets, supporting the intended therapeutic effect.


Q: What is the maximum duration for which Whitefield is typically used?

A: A typical course of treatment lasts several weeks until the symptoms are completely resolved. However, official warnings advise against prolonged use or application over large areas to mitigate the risk of systemic absorption of the ingredients and related toxicity.


Q: Does Whitefield help relieve the itching and discomfort of a fungal infection?

A: Clinical trials for the product often measure clinical efficacy by assessing the reduction in mean signs and symptom scores. These scores typically include the assessment of clinical improvement in symptoms such as itching and general discomfort associated with fungal infections.

How should Whitefield be stored and disposed of?

Storage and Disposal Requirements for Whitfield Ointment

This section outlines the officially documented storage and disposal requirements for Compound Benzoic Acid Ointment, strictly based on regulatory labeling.


Storage Conditions

Requirement Official Instruction
Temperature Store at a temperature not exceeding 30°C; some documents specify below 25°C or between 10 C to 25 C.
Protection Protect from light and moisture.
Prohibition Do not freeze the product.
Container Store in a tight container and keep the cap securely closed.
Child Safety Keep out of the sight and reach of children.

Disposal Instructions

Disposal of unused or expired ointment must be performed in accordance with local requirements. It is generally advised not to dispose of medicine via wastewater or household waste unless instructed by regulators. The preferred method is often to use an approved drug take-back program. If a take-back option is unavailable, the product may be mixed with an undesirable substance and sealed before disposal in the trash, and personal information must be removed from the label.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Whitefield found in:

A-Z Index: